Lee Shan
Corporate Officer/Principal bei BIOMICS BIOPHARMA LTD
Profil
Lee Shan is currently the Vice President-Business & Market Development at Biomics Biotechnologies Co., Ltd.
and the Head-Business & Market Development at Biomics Biopharma Ltd.
Previously, he held positions as the Director-Business Development at Austarpharma, Inc., Principal at Cardinal Health, Inc., Principal at Cencora, Inc., Principal at the University of South Dakota, and Principal at Qilu Pharmaceutical Co., Ltd.
He has an MBA from Concordia University, a graduate degree from the University of South Dakota, and an undergraduate degree from Shandong University.
Aktive Positionen von Lee Shan
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOMICS BIOPHARMA LTD | Corporate Officer/Principal | - |
Biomics Biotechnologies Co., Ltd.
 Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Lee Shan
| Unternehmen | Position | Ende |
|---|---|---|
Qilu Pharmaceutical Co., Ltd.
 Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Corporate Officer/Principal | - |
Austarpharma, Inc.
 Austarpharma, Inc. Pharmaceuticals: MajorHealth Technology Austarpharma, Inc. engages in drug delivery technology platforms. It offers osmotic pump, matrix, film, pulsatile, formulation and analytical development, and higher shear granulation. The company was founded by Ron Liu in 2004 and is headquartered in Edison, NJ. | Corporate Officer/Principal | - |
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | - |
| University of South Dakota | Corporate Officer/Principal | - |
| CENCORA, INC. | Corporate Officer/Principal | - |
Ausbildung von Lee Shan
| Concordia University | Masters Business Admin |
| University of South Dakota | Graduate Degree |
| Shandong University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| CENCORA, INC. | Distribution Services |
| BIOMICS BIOPHARMA LTD | Process Industries |
| Private Unternehmen | 3 |
|---|---|
Biomics Biotechnologies Co., Ltd.
Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Health Technology |
Austarpharma, Inc.
Austarpharma, Inc. Pharmaceuticals: MajorHealth Technology Austarpharma, Inc. engages in drug delivery technology platforms. It offers osmotic pump, matrix, film, pulsatile, formulation and analytical development, and higher shear granulation. The company was founded by Ron Liu in 2004 and is headquartered in Edison, NJ. | Health Technology |
Qilu Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Health Technology |
